Higher levels of phosphorylated tau 217, or p-tau217, were strongly associated with future mild cognitive impairment and dementia -- of which Alzheimer's disease is the most common form -- among older women who were cognitively healthy at the study's start.
from Top Health News | Latest Healthcare Sector & Healthcare Industry news, Information and Updates: ET HealthWorld : ETHealthworld.com https://ift.tt/16g2SIO
Home »
Information and Updates: ET HealthWorld : ETHealthworld.com
,
Top Health News | Latest Healthcare Sector & Healthcare Industry news
,
IFTTT
» Blood biomarker may help predict woman's dementia risk 25 years before symptoms